Published in J Immunol Methods on February 27, 1986
Histopathological and serological progression of experimental Staphylococcus aureus arthritis. Infect Immun (1992) 2.64
Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit. Infect Immun (1996) 1.71
Role of neutrophil leukocytes in cutaneous infection caused by Staphylococcus aureus. Infect Immun (2000) 1.65
Inhibition of Streptococcus mutans adherence to saliva-coated hydroxyapatite by human secretory immunoglobulin A (S-IgA) antibodies to cell surface protein antigen I/II: reversal by IgA1 protease cleavage. Infect Immun (1992) 1.37
Differences in immune responses induced by oral and rectal immunizations with Salmonella typhi Ty21a: evidence for compartmentalization within the common mucosal immune system in humans. Infect Immun (1998) 1.36
Limited local and systemic antibody responses to Neisseria gonorrhoeae during uncomplicated genital infections. Infect Immun (1999) 1.36
Women with cervicovaginal antibody-dependent cell-mediated cytotoxicity have lower genital HIV-1 RNA loads. J Infect Dis (2004) 1.33
Oestrogen is a potent disease accelerator in SLE-prone MRL lpr/lpr mice. Clin Exp Immunol (1990) 1.26
Oestradiol- and testosterone-mediated effects on the immune system in normal and autoimmune mice are genetically linked and inherited as dominant traits. Immunology (1989) 1.15
Immunopathological features of rat Staphylococcus aureus arthritis. Infect Immun (1994) 1.08
Complement depletion aggravates Staphylococcus aureus septicaemia and septic arthritis. Clin Exp Immunol (1999) 1.06
Role of gamma/delta T cell receptor-expressing lymphocytes in cutaneous infection caused by Staphylococcus aureus. Clin Exp Immunol (2003) 1.01
Analysis of the genetic encoding of oestradiol suppression of delayed-type hypersensitivity in (NZB x NZW) F1 mice. Immunology (1991) 1.00
Subclass distribution of salivary secretory immunoglobulin A antibodies to oral streptococci. Infect Immun (1991) 0.97
Evaluation of immunoglobulin A1 (IgA1) protease and IgA1 protease-inhibitory activity in human female genital infection with Neisseria gonorrhoeae. Infect Immun (1998) 0.93
Immunological cross-reactivity between Streptococcus mutans and human heart tissue examined by cross-immunization experiments. Infect Immun (1990) 0.90
Cellular origins of human polymeric and monomeric IgA: enumeration of single cells secreting polymeric IgA1 and IgA2 in peripheral blood, bone marrow, spleen, gingiva and synovial tissue. Clin Exp Immunol (1991) 0.85
Intra-articular immunization induces strong systemic immune response in humans. Clin Exp Immunol (1990) 0.79
A rapid and simple method for preparation of RNA from Saccharomyces cerevisiae. Nucleic Acids Res (1990) 11.96
The common mucosal immune system and current strategies for induction of immune responses in external secretions. J Clin Immunol (1987) 5.30
Terminology: nomenclature of mucosa-associated lymphoid tissue. Mucosal Immunol (2008) 5.28
Making ends meet: a model for RNA splicing in fungal mitochondria. Nature (1982) 5.27
Convergence of Ets- and notch-related structural motifs in a heteromeric DNA binding complex. Science (1991) 4.98
Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv Immunol (1987) 4.53
Protein antigens of Streptococcus mutans: purification and properties of a double antigen and its protease-resistant component. Infect Immun (1980) 4.36
The mucosal immune system: from fundamental concepts to vaccine development. Vaccine (1992) 3.99
Primary and subsequent coronary risk appraisal: new results from the Framingham study. Am Heart J (2000) 3.61
Multicenter collaborative panic disorder severity scale. Am J Psychiatry (1997) 3.29
Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int (2007) 3.17
Characterisation of antigens extracted from cells and culture fluids of Streptococcus mutans serotype c. Arch Oral Biol (1978) 3.03
Antibodies to native and denatured collagens in sera of patients with rheumatoid arthritis. Arthritis Rheum (1976) 2.97
Ingestion of Streptococcus mutans induces secretory immunoglobulin A and caries immunity. Science (1976) 2.78
Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest (1999) 2.77
Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues. Infect Immun (1989) 2.74
Immunization with purified protein antigens from Streptococcus mutans against dental caries in rhesus monkeys. Infect Immun (1981) 2.72
Selective induction of an immune response in human external secretions by ingestion of bacterial antigen. J Clin Invest (1978) 2.64
Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines. J Virol (1998) 2.63
Idiopathic paraproteinemia. II. Transplantation of the paraprotein-producing clone from old to young C57BL/KaLwRij mice. J Immunol (1979) 2.60
Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infect Immun (1993) 2.58
Pathogenic species of the genus Haemophilus and Streptococcus pneumoniae produce immunoglobulin A1 protease. Infect Immun (1979) 2.57
The bone marrow: the major source of serum immunoglobulins, but still a neglected site of antibody formation. Clin Exp Immunol (1981) 2.54
Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae. J Infect Dis (1997) 2.50
Defense mechanisms involving Fc-dependent functions of immunoglobulin A and their subversion by bacterial immunoglobulin A proteases. Microbiol Rev (1988) 2.50
Establishment of a Streptococcus pneumoniae nasopharyngeal colonization model in adult mice. Microb Pathog (1997) 2.41
Social fears and social phobia in the USA: results from the National Comorbidity Survey Replication. Psychol Med (2007) 2.41
IgA antibody-producing cells in peripheral blood after antigen ingestion: evidence for a common mucosal immune system in humans. Proc Natl Acad Sci U S A (1987) 2.37
Secretory component of epithelial cells is a surface receptor for polymeric immunoglobulins. J Exp Med (1978) 2.26
IgA1 proteases from Haemophilus influenzae, Streptococcus pneumoniae, Neisseria meningitidis, and Streptococcus sanguis: comparative immunochemical studies. J Immunol (1980) 2.23
Different subclass distribution of IgA-producing cells in human lymphoid organs and various secretory tissues. J Immunol (1986) 2.20
Human immune responses to influenza virus vaccines administered by systemic or mucosal routes. Vaccine (1995) 2.06
Immunoglobulin M and secretory immunoglobulin A: presence of a common polypeptide chain different from light chains. Science (1971) 2.03
IgA nephropathy, the most common glomerulonephritis worldwide. A neglected disease in the United States? Am J Med (1988) 2.02
Close relationship between certain nuclear and mitochondrial introns. Implications for the mechanism of RNA splicing. J Mol Biol (1983) 1.98
Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities. J Immunol (2001) 1.95
Immunoglobulin A (IgA). Methods Enzymol (1985) 1.94
A novel two colour ELISPOT assay. I. Simultaneous detection of distinct types of antibody-secreting cells. J Immunol Methods (1988) 1.91
Mucosal immunization with a bacterial protein antigen genetically coupled to cholera toxin A2/B subunits. J Immunol (1995) 1.89
Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int (1997) 1.88
Naturally occurring secretory immunoglobulin A antibodies to Streptococcus mutans in human colostrum and saliva. Infect Immun (1976) 1.85
Biodegradable block copolymers for delivery of proteins and water-insoluble drugs. J Control Release (2001) 1.85
Attitudinal body-image assessment: factor analysis of the Body-Self Relations Questionnaire. J Pers Assess (1990) 1.84
DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma. Nat Med (1998) 1.83
Synergistic effect of IL-4 and IFN-gamma on the expression of polymeric Ig receptor (secretory component) and IgA binding by human epithelial cells. J Immunol (1990) 1.82
IgA-induced eosinophil degranulation. J Immunol (1989) 1.82
Subclass distribution and molecular form of immunoglobulin A hemagglutinin antibodies in sera and nasal secretions after experimental secondary infection with influenza A virus in humans. J Clin Microbiol (1985) 1.80
Hyperimmunoglobulinaemia D and periodic fever: a new syndrome. Lancet (1984) 1.79
A novel mechanism for the insulin-like effect of vanadate on glycogen synthase in rat adipocytes. J Biol Chem (1984) 1.79
Distribution of IgA1-, IgA2-, and J chain-containing cells in human tissues. J Immunol (1984) 1.78
Regulation of IgA synthesis and immune response by T cells and interleukins. J Clin Immunol (1989) 1.76
Affinity and specificity of the interactions between Streptococcus mutans antigen I/II and salivary components. J Dent Res (1994) 1.75
Influence of treatment with APD-bisphosphonate on the bone lesions in the mouse 5T2 multiple myeloma. Cancer (1985) 1.74
Murine model for evaluation of protective immunity to influenza virus. Vaccine (1993) 1.73
Tissue origins of human polymeric and monomeric IgA. J Immunol (1982) 1.73
Oral tolerance in humans. T cell but not B cell tolerance after antigen feeding. J Immunol (1994) 1.72
Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit. Infect Immun (1996) 1.71
Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies. J Clin Invest (1986) 1.70
Purification and properties of a protein surface antigen of Streptococcus mutants. Microbios (1979) 1.67
Characterization of antibodies to the native human collagens and to their component alpha chains in the sera and the joint fluids of patients with rheumatoid arthritis. Immunochemistry (1976) 1.67
The human IgA system: a reassessment. Clin Immunol Immunopathol (1986) 1.64
Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group. J Infect Dis (1998) 1.64
Heterosubtypic immunity to lethal influenza A virus infection is associated with virus-specific CD8(+) cytotoxic T lymphocyte responses induced in mucosa-associated tissues. Virology (1999) 1.63
Studies on human secretory immunoglobulin A. II. Subunit structure. J Immunol (1972) 1.62
Heterosubtypic immunity to influenza A virus infection requires B cells but not CD8+ cytotoxic T lymphocytes. J Infect Dis (2000) 1.61
Immunisation with a purified protein from Streptococcus mutans against dental caries in rhesus monkeys. Lancet (1980) 1.61
Passage of immunoglobulins from plasma to the oral cavity in rhesus monkeys. Immunology (1978) 1.60
Differential homing commitments of antigen-specific T cells after oral or parenteral immunization in humans. J Immunol (1999) 1.60
Secretory immunoglobulin A carries oligosaccharide receptors for Escherichia coli type 1 fimbrial lectin. Infect Immun (1990) 1.60
IgA subclasses. Monogr Allergy (1986) 1.57
Reliability of DSM-III-R anxiety disorder categories. Using the Anxiety Disorders Interview Schedule-Revised (ADIS-R). Arch Gen Psychiatry (1993) 1.55
Cloning and characterization of a novel member of the transforming growth factor-beta/bone morphogenetic protein family. J Biol Chem (1998) 1.55
Internal structure of a mitochondrial intron of Aspergillus nidulans. Proc Natl Acad Sci U S A (1982) 1.53
A murine model of human myeloma bone disease. Bone (1997) 1.53
Immunoglobulin A subclass distribution of naturally occurring salivary antibodies to microbial antigens. Infect Immun (1985) 1.53
A comprehensive genetic study of streptococcal immunoglobulin A1 proteases: evidence for recombination within and between species. Infect Immun (1998) 1.52
Identification of osteoblast/osteocyte factor 45 (OF45), a bone-specific cDNA encoding an RGD-containing protein that is highly expressed in osteoblasts and osteocytes. J Biol Chem (2000) 1.52
Variations in immunoglobulins and IgA subclasses of human uterine cervical secretions around the time of ovulation. Clin Exp Immunol (1996) 1.51
Role of serum IgA. Hepatobiliary transport of circulating antigen. J Exp Med (1981) 1.49
Idiopathic paraproteinaemia. I. Studies in an animal model--the ageing C57BL/KaLwRij mouse. Clin Exp Immunol (1978) 1.48
Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system. Immunol Res (1997) 1.48
Nasal lymphoid tissue (NALT) as a mucosal immune inductive site. Scand J Immunol (1997) 1.48
Concept of the local and common mucosal immune response. Adv Exp Med Biol (1978) 1.46